Brian D. Ford
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian D. Ford
Earlier roles on record: CFO at Grace Therapeutics, Inc. (GRCE) until January 5, 2024. Grace Therapeutics, Inc. reported in an 8-K filed January 8, 2024 that Brian D. Ford was terminated as interim-Chief Financial Officer, effective January 5, 2024. Grace Therapeutics, Inc. reported in an 8-K filed May 11, 2023 that Brian D. Ford was terminated as Chief Financial Officer, effective May 8, 2023.
“Concurrently with such appointment, the Board removed Brian Ford from the position of interim-Chief Financial Officer.”
“On May 8, 2023, the Company terminated the employment of Brian Ford, Chief Financial Officer; Pierre Lemieux, Chief Operating Officer (Canada); and George Kottayil, Chief Operating Officer (US).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-09-14–2024-01-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.